Cargando…

Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs

Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic β-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Qingyue, Sun, Jie, Xie, Wenting, Bai, Yuman, Wang, Shuzhou, Huang, Jianjia, Zhou, Shuilian, Li, Quanwei, Zhang, Hui, Tang, Zhaoxin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377912/
https://www.ncbi.nlm.nih.gov/pubmed/35978645
http://dx.doi.org/10.1155/2022/5422287
_version_ 1784768434291081216
author Han, Qingyue
Sun, Jie
Xie, Wenting
Bai, Yuman
Wang, Shuzhou
Huang, Jianjia
Zhou, Shuilian
Li, Quanwei
Zhang, Hui
Tang, Zhaoxin
author_facet Han, Qingyue
Sun, Jie
Xie, Wenting
Bai, Yuman
Wang, Shuzhou
Huang, Jianjia
Zhou, Shuilian
Li, Quanwei
Zhang, Hui
Tang, Zhaoxin
author_sort Han, Qingyue
collection PubMed
description Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic β-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on the use of beagle dogs to establish an animal model of type 1 diabetes. This study aimed to explore a simple and feasible modeling method to establish a long-term and stable type 1 diabetes model in beagle dogs. Forty adult beagle dogs were randomly divided into control group and model group. After 24 h of fasting, streptozotocin (20 mg/kg) and alloxan (20 mg/kg) were injected through the cephalic vein. The second intravenous injection was given on the 4th day after the first injection. Insulin release testing was performed on the 7th day after the last intravenous injection. Fasting blood glucose and body weight were recorded monthly. Four months after the last injection, the serum fructosamine content and the ratio of glycated hemoglobin were detected. Then, the pancreatic tissue was harvested for histopathological examination. The results showed that the level of fasting blood glucose of the 16 dogs in the model group was consistently higher than 11.1 mmol/L for 4 consecutive months. Moreover, compared with the control group, the insulin release curve of the model group was flat with no increase. The body weight of the model group was significantly reduced, and the ratios of blood glucose, fructosamine, and glycosylated hemoglobin were significantly higher than those in the control group. Meanwhile, histopathological examination of the pancreas showed that the islet beta cells appeared to have vacuoles or even necrosis. In the model group, pancreatic β-cells were damaged and insulin release was reduced. These results suggest that the above modeling methods can induce long-term and stable type 1 diabetes models in beagle dogs.
format Online
Article
Text
id pubmed-9377912
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-93779122022-08-16 Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs Han, Qingyue Sun, Jie Xie, Wenting Bai, Yuman Wang, Shuzhou Huang, Jianjia Zhou, Shuilian Li, Quanwei Zhang, Hui Tang, Zhaoxin Biomed Res Int Research Article Type 1 diabetes mellitus (T1DM) is a chronic disease represented by insulin-causing pancreatic β-cell disruption and hyperglycemia. Therefore, it is necessary to establish a variety of animal models of diabetes to study the pathogenesis and pathophysiology of it. However, there are few reports on the use of beagle dogs to establish an animal model of type 1 diabetes. This study aimed to explore a simple and feasible modeling method to establish a long-term and stable type 1 diabetes model in beagle dogs. Forty adult beagle dogs were randomly divided into control group and model group. After 24 h of fasting, streptozotocin (20 mg/kg) and alloxan (20 mg/kg) were injected through the cephalic vein. The second intravenous injection was given on the 4th day after the first injection. Insulin release testing was performed on the 7th day after the last intravenous injection. Fasting blood glucose and body weight were recorded monthly. Four months after the last injection, the serum fructosamine content and the ratio of glycated hemoglobin were detected. Then, the pancreatic tissue was harvested for histopathological examination. The results showed that the level of fasting blood glucose of the 16 dogs in the model group was consistently higher than 11.1 mmol/L for 4 consecutive months. Moreover, compared with the control group, the insulin release curve of the model group was flat with no increase. The body weight of the model group was significantly reduced, and the ratios of blood glucose, fructosamine, and glycosylated hemoglobin were significantly higher than those in the control group. Meanwhile, histopathological examination of the pancreas showed that the islet beta cells appeared to have vacuoles or even necrosis. In the model group, pancreatic β-cells were damaged and insulin release was reduced. These results suggest that the above modeling methods can induce long-term and stable type 1 diabetes models in beagle dogs. Hindawi 2022-08-08 /pmc/articles/PMC9377912/ /pubmed/35978645 http://dx.doi.org/10.1155/2022/5422287 Text en Copyright © 2022 Qingyue Han et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Han, Qingyue
Sun, Jie
Xie, Wenting
Bai, Yuman
Wang, Shuzhou
Huang, Jianjia
Zhou, Shuilian
Li, Quanwei
Zhang, Hui
Tang, Zhaoxin
Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
title Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
title_full Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
title_fullStr Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
title_full_unstemmed Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
title_short Repeated Low-Dose Streptozotocin and Alloxan Induced Long-Term and Stable Type 1 Diabetes Model in Beagle Dogs
title_sort repeated low-dose streptozotocin and alloxan induced long-term and stable type 1 diabetes model in beagle dogs
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377912/
https://www.ncbi.nlm.nih.gov/pubmed/35978645
http://dx.doi.org/10.1155/2022/5422287
work_keys_str_mv AT hanqingyue repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT sunjie repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT xiewenting repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT baiyuman repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT wangshuzhou repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT huangjianjia repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT zhoushuilian repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT liquanwei repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT zhanghui repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs
AT tangzhaoxin repeatedlowdosestreptozotocinandalloxaninducedlongtermandstabletype1diabetesmodelinbeagledogs